Epicore Biosystems Secures $32M Series B Funding to Revolutionize Digital Health with Advanced Sweat-Sensing Wearables

Epicore Biosystems is thrilled to announce that it has successfully raised $32,000,000 in its latest funding round, marking a pivotal milestone in the company’s journey to revolutionize digital health. As innovators in the wearable technology space, Epicore Biosystems is dedicated to developing advanced sweat-sensing wearables that provide real-time, personalized health insights for hydration, stress, and overall wellness. This fresh infusion of capital will enable the company to further accelerate its research and development efforts, ensuring that its clinically validated products continue to meet the high standards of accuracy and reliability expected by users around the world. With this new funding, Epicore Biosystems is set to expand its product portfolio and refine its existing technology, making these breakthrough devices even more accessible to a broader audience in key sectors such as sports and fitness, occupational safety, and clinical trials. The company’s commitment to innovation is matched only by its dedication to improving health outcomes, and this funding round will play a critical role in enhancing its capabilities in data analytics and sensor integration. By leveraging these insights, Epicore Biosystems aims to empower leading brands to deliver enhanced personalized wellness solutions, setting new benchmarks for health monitoring in dynamic environments. This investment not only underscores the confidence of investors in Epicore Biosystems’ vision for the future of digital health but also reinforces its position as a global leader in wearable technology. As the company grows its global footprint, it remains steadfast in its mission to provide users with actionable health insights that can drive both performance and well-being across diverse lifestyles and professional settings.